Arlington, TN-based Wright Medical Group last month launched its MiToe patient outreach program to increase patients’ awareness of treatment options for hammertoes.
Wright introduced the program to practitioners at the June meeting of the American Orthopaedic Foot & Ankle Society, held in San Diego. MiToe is the patient-facing brand for the company’s hammertoe products, including the Pro-Toe implant. The program website is now live at www.mitoe.com.
Robert Palmisano, Wright Medical’s CEO, noted, “This patient education site…is part of our company’s focus on growing our foot and ankle business faster than the market rate by targeting the largest sufferers of painful hammertoes—women in their 40s to 60s. Our objective with this website launch is to educate patients and encourage them to visit a foot and ankle specialist and ask about treatment options, including the MiToe implant.”